28232384|t|The E3 Ligase CHIP Mediates p21 Degradation to Maintain Radioresistance
28232384|a|Lung cancer resists radiotherapy, making it one of the deadliest forms of cancer. Here, we show that human lung cancer cell lines can be rendered sensitive to ionizing radiation (IR) by RNAi knockdown of C-terminus of Hsc70-interacting protein (CHIP / STUB1), a U-box-type E3 ubiquitin ligase that targets a number of stress-induced proteins. Mechanistically, ubiquitin-dependent degradation of the cyclin-dependent kinase (CDK) inhibitor, p21 protein, is reduced by CHIP knockdown, leading to enhanced senescence of cells in response to exposure to IR. Cellular senescence and sensitivity to IR is prevented by CRISPR / Cas9 -mediated deletion of the p21 gene (CDKN1A) in CHIP knockdown cells. Conversely, overexpression of CHIP potentiates p21 degradation and promotes greater radioresistance of lung cancer cells. In vitro and cell -based assays demonstrate that p21 is a novel and direct ubiquitylation substrate of CHIP that also requires the CHIP - associated chaperone HSP70. These data reveal that the inhibition of the E3 ubiquitin ligase CHIP promotes radiosensitivity, thus suggesting a novel strategy for the treatment of lung cancer. Implications: The CHIP - HSP70 - p21 ubiquitylation / degradation axis identified here could be exploited to enhance the efficacy of radiotherapy in patients with non-small cell lung cancer. Mol Cancer Res; 1-9. Â©2017 AACR.
28232384	4	18	E3 Ligase CHIP	T116,T126	C1172009
28232384	28	31	p21	T116,T123	C0919418
28232384	32	43	Degradation	T169	C0243125
28232384	47	55	Maintain	T052	C0024501
28232384	56	71	Radioresistance	T077	C3890377
28232384	72	83	Lung cancer	T191	C0684249
28232384	84	91	resists	T169	C4281815
28232384	92	104	radiotherapy	T060	C0948315
28232384	146	152	cancer	T191	C0006826
28232384	173	178	human	T016	C0086418
28232384	179	190	lung cancer	T191	C0684249
28232384	191	201	cell lines	T025	C0007600
28232384	218	227	sensitive	T169	C0332324
28232384	231	249	ionizing radiation	T070	C0034538
28232384	251	253	IR	T070	C0034538
28232384	258	262	RNAi	T045	C1136031
28232384	263	272	knockdown	T063	C2350567
28232384	276	315	C-terminus of Hsc70-interacting protein	T116,T126	C1172009
28232384	317	321	CHIP	T116,T126	C1172009
28232384	324	329	STUB1	T116,T126	C1172009
28232384	334	364	U-box-type E3 ubiquitin ligase	T116,T126	C0077678
28232384	370	377	targets	T169	C1521840
28232384	390	413	stress-induced proteins	T116,T123	C1336511
28232384	432	463	ubiquitin-dependent degradation	T044	C1157991
28232384	471	523	cyclin-dependent kinase (CDK) inhibitor, p21 protein	T116,T123	C0919418
28232384	528	535	reduced	T080	C0392756
28232384	539	543	CHIP	T028	C1420492
28232384	544	553	knockdown	T063	C2350567
28232384	575	594	senescence of cells	T043	C0007581
28232384	598	606	response	T032	C0871261
28232384	610	624	exposure to IR	T037	C0479513
28232384	626	645	Cellular senescence	T043	C0007581
28232384	650	661	sensitivity	T169	C0332324
28232384	665	667	IR	T070	C0034538
28232384	671	680	prevented	T169	C1292733
28232384	684	690	CRISPR	T114	C3658200
28232384	693	697	Cas9	T116	C3658265
28232384	708	716	deletion	T045	C0017260
28232384	724	732	p21 gene	T028	C0249197
28232384	734	740	CDKN1A	T028	C0249197
28232384	745	749	CHIP	T028	C1420492
28232384	750	759	knockdown	T063	C2350567
28232384	760	765	cells	T025	C0007634
28232384	779	793	overexpression	T045	C1514559
28232384	797	801	CHIP	T116,T126	C1172009
28232384	802	813	potentiates	T080	C0442803
28232384	814	817	p21	T116,T123	C0919418
28232384	818	829	degradation	T169	C0243125
28232384	834	842	promotes	T052	C0033414
28232384	843	850	greater	T081	C1704243
28232384	851	866	radioresistance	T077	C3890377
28232384	870	881	lung cancer	T191	C0684249
28232384	882	887	cells	T025	C0007634
28232384	889	897	In vitro	T080	C1533691
28232384	902	906	cell	T025	C0007634
28232384	914	920	assays	T059	C0005507
28232384	938	941	p21	T116,T123	C0919418
28232384	947	952	novel	T080	C0205314
28232384	964	978	ubiquitylation	T044	C1519751
28232384	979	988	substrate	T167	C3891814
28232384	992	996	CHIP	T116,T126	C1172009
28232384	1020	1024	CHIP	T116,T126	C1172009
28232384	1027	1037	associated	T080	C0332281
28232384	1038	1047	chaperone	T116,T123	C0243041
28232384	1048	1053	HSP70	T116,T123	C0243043
28232384	1061	1065	data	T078	C1511726
28232384	1066	1072	reveal	T080	C0443289
28232384	1082	1092	inhibition	T052	C3463820
28232384	1100	1124	E3 ubiquitin ligase CHIP	T116,T126	C1172009
28232384	1125	1133	promotes	T052	C0033414
28232384	1134	1150	radiosensitivity	T032	C0034537
28232384	1193	1202	treatment	T061	C0087111
28232384	1206	1217	lung cancer	T191	C0684249
28232384	1219	1231	Implications	T078	C1707478
28232384	1237	1241	CHIP	T116,T126	C1172009
28232384	1244	1249	HSP70	T116,T123	C0243043
28232384	1252	1255	p21	T116,T123	C0919418
28232384	1256	1270	ubiquitylation	T044	C1519751
28232384	1273	1284	degradation	T169	C0243125
28232384	1285	1289	axis	T082	C1522496
28232384	1290	1300	identified	T080	C0205396
28232384	1315	1324	exploited	T169	C0457083
28232384	1340	1348	efficacy	T080	C1280519
28232384	1352	1364	radiotherapy	T061	C1522449
28232384	1368	1376	patients	T101	C0030705
28232384	1382	1408	non-small cell lung cancer	T191	C0007131